RARECast
Ein Podcast von RARECast - Donnerstags
Kategorien:
512 Folgen
-
Lessons from Pitching Venture Capitalists
Vom: 15.11.2017 -
Health Canada Scraps Plans for Orphan Drug Framework
Vom: 8.11.2017 -
New Investment Boosts Rare Disease Drug Accelerator
Vom: 1.11.2017 -
Understanding Rare Disease Caregiver Needs
Vom: 25.10.2017 -
Deriving Rare Disease Therapies from Human Plasma
Vom: 18.10.2017 -
Learning to Live with Purpose
Vom: 11.10.2017 -
A Mother's Race to Find a Treatment for Her Daughter's Ultra-Rare Condition
Vom: 4.10.2017 -
Screening for Rare Diseases
Vom: 27.9.2017 -
A Look at the Changing World of Work for People with a Chronic Illness
Vom: 20.9.2017 -
Aligning Interests in Rare Disease Partnerships
Vom: 13.9.2017 -
A Veteran Venture Capitalist Discusses Investing in Rare Disease Drug Development
Vom: 6.9.2017 -
A Patient Group Crafts Guidelines for Working with Pharma
Vom: 30.8.2017 -
Bringing Innovation to Business Models for Rare Disease Drug Development
Vom: 23.8.2017 -
Rethinking Accessibility and Dependency
Vom: 16.8.2017 -
How Simon Wheatcroft, Blinded by a Rare Disease, Became an Ultramarathoner
Vom: 9.8.2017 -
Spark Hoping Its Luxturna Will Become First FDA-Approved Gene Therapy
Vom: 2.8.2017 -
What Rare Patient-Investors Can Learn From Venture Capitalists
Vom: 26.7.2017 -
Novel Effort Delivers Failed DMD Drug to Former Clinical Trial Participants
Vom: 19.7.2017 -
Centogene Seeks to Deliver Diagnoses to Rare Disease Patients Early
Vom: 12.7.2017 -
Albireo Advances Pipeline for Rare Liver and Gastrointestinal Diseases
Vom: 5.7.2017
RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.